Internal Server Error

Micro CRISPR - About the company

Micro CRISPR is an unfunded company based in Valsad (India), founded in 2021. It operates as a Developer of CRISPR technology based therapeutics to treat various diseases. Micro CRISPR has not raised any funding yet. The company has 1769 active competitors, including 266 funded and 279 that have exited. Its top competitors include companies like Amgen, AbbVie and Gilead.

Company Details

Developer of CRISPR technology based therapeutics to treat various diseases. The company has MyCART and OmniCART platforms to develop a next-generation allogeneic CAR T-cell therapy by using CRISPR technology to knock out genes from the T-cells that are responsible for graft-vs-host disease for the treatment of cancer.
Email ID
*****@micro-crispr.com
Registered Address
135/139, MUKTANAND MARG, BILAKHIA HOUSE, CHALA, VAPI-WEST, Valsad, VAPI, Gujarat, India, 396191
Key Metrics
Founded Year
2021
Location
Valsad, India
Stage
Unfunded
Ranked
Annual Revenue
₹3.08Cr as on Mar 31, 2025
Employee Count
177 as on Jun 30, 2024
Similar Companies
Sign up to download Micro CRISPR's company profile

Micro CRISPR's funding and investors

Micro CRISPR has not raised any funding rounds yet.

Micro CRISPR's founders and board of directors

Founder? Claim Profile

Micro CRISPR's employee count trend

Micro CRISPR has 177 employees as of Jun 24. The total employee count is 119.0% more than what it was in Jun 23. Here is Micro CRISPR's employee count trend over the years:
Employee count trend for Micro CRISPR
lockUncover Micro CRISPR's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Micro CRISPR's Competitors and alternates

Top competitors of Micro CRISPR include Amgen, AbbVie and Gilead. Here is the list of Top 10 competitors of Micro CRISPR, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Amgen
Amgen
1980, Thousand Oaks (United States), Public
Developer of pharmaceutical products for treating multiple diseases
-
83/100
2nd
Logo for AbbVie
AbbVie
2012, Chicago (United States), Public
Research-based biopharmaceutical company
$14.7B
81/100
3rd
Logo for Gilead
Gilead
1987, Foster City (United States), Public
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
-
81/100
4th
Logo for Lilly
Lilly
1876, Indianapolis (United States), Public
Developer of traditional pharmaceutical medicines
-
80/100
5th
Logo for Alnylam
Alnylam
2002, Cambridge (United States), Public
Developer of RNA interference-based therapeutics for multiple disorders
$17M
79/100
6th
Logo for Johnson & Johnson
Johnson & Johnson
1886, New Brunswick (United States), Public
Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products
-
78/100
7th
Logo for Pfizer
Pfizer
1849, New York City (United States), Public
Provider of pharmaceutical products for multiple disease treatments
-
77/100
8th
Logo for Sana Biotechnology
Sana Biotechnology
2018, Seattle (United States), Public
Developer of genetically engineered cell therapies for multiple disorders
$821M
75/100
9th
Logo for Juno Therapeutics
Juno Therapeutics
2013, Seattle (United States), Acquired
Global biopharmaceutical company discovering, developing, and delivering innovative medicines
$317M
74/100
10th
Logo for Spark Therapeutics
Spark Therapeutics
2013, Philadelphia (United States), Acquired
Developer of gene therapy for rare diseases
$82.8M
74/100
258th
Logo for Micro CRISPR
Micro CRISPR
2021, Valsad (India), Unfunded
Developer of CRISPR technology based therapeutics to treat various diseases
-
-
45/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Micro CRISPR's competitors? Click here to see the top ones

Micro CRISPR's Investments and acquisitions

Micro CRISPR has made no investments or acquisitions yet.

Reports related to Micro CRISPR

Here is the latest report on Micro CRISPR's sector:

FAQs about Micro CRISPR

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford